Nano Medtech


They have engineered polylactic-co-glycolic acid (PLGA) immunonanoparticles specifically for targeting invasive epithelial tumour cells.
This company is working on the base of traditional Chinese medicine. They focuses on human application of nano-technology, especially in the area of cancer treatment. Monoclonal antibody (mAb) are used as a homing ligand and attached to the nanoparticle surface either covalently or non-covalently as required. Protein assay, surface plasmon resonance Nanoparticle mAb binding MCF-10A neoT cell targeting Caco-2 cells immunonanoparticles Immunostaining Monitoring. As they say: "Specific targeting of generic malignant cells or tissue is now possible through the utilization of immuno-nanoparticles. Nano Robots / nanoparticles by which mAbs can be bound without detriment to their targeting ability, shows an applied effectiveness as a new carrier system for the delivery of small or large active substances into cells or tissues of interests."
Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |
Nano Medtech1001 Tian Lin Road, Caohejin, Hi-Tech Park |
Share with friends:
Next companies in category
Nanotechnology in medicine | Nano materials | Nanotechnology electronics | Nano asociation |
Follow Nanotechnology Journal on
© 2008 - 2025 Nanotechnology research | All rights reserved | Developed by Makovic.net